|
124I-cG250 ImmunoPET Imaging of Sunitinib Treatment Response in Renal Cell Cancer
|
5R21CA162602-02
|
$379,518
|
Larson, Steven
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
3D-Adhesion Stromagenesis in Cancer Permissiveness
|
2R01CA113451-06A1
|
$245,775
|
CUKIERMAN, EDNA
|
INSTITUTE FOR CANCER RESEARCH
|
|
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
|
ZIABC011232
|
$306,950
|
Barchi, Joseph
|
CCR (NCI)
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196-03152
|
$1,258,475
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-36
|
$7,725,062
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
AIDS Malignancy Clinical Trials Consortium (AMC)
|
3U01CA121947-05S1
|
$450,000
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA AT LOS ANGELES
|
|
AIDS Malignancy Clinical Trials Consortium (AMC)
|
5U01CA121947-06
|
$6,010,333
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA AT LOS ANGELES
|
|
Anatomic Pathology Residency Program
|
ZIEBC011384
|
$1,082,541
|
Oberholtzer, John
|
CCR (NCI)
|
|
Applied Molecular Pathology Laboratory
|
ZICBC011257
|
$168,894
|
Hewitt, Stephen
|
CCR (NCI)
|
|
Arginase Production in Cancer: Evading Immune Response
|
5R01CA107974-07
|
$294,654
|
OCHOA, AUGUSTO
|
LOUISIANA STATE UNIV HSC NEW ORLEANS
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,176,890
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Atlanta Regional Community Clinical Oncology Program (ARCCOP)
|
5U10CA045450-26
|
$562,599
|
SEAY, THOMAS
|
ST. JOSEPH'S HOSPITAL
|
|
B7-H1/PD-1 modulation in cancer therapy
|
5R01CA142779-03
|
$471,842
|
PARDOLL, DREW
|
JOHNS HOPKINS UNIVERSITY
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV/AIDS Research
|
ZIGBC010856
|
$14,609,987
|
Custer, Mary
|
CCR (NCI)
|
|
Bay Area Tumor Institute CCOP
|
2U10CA045461-23
|
$486,165
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
Beaumont Community Clinical Oncology Program
|
3U10CA095860-11S1
|
$140,000
|
Robertson, John
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
Beaumont Community Clinical Oncology Program
|
5U10CA095860-11
|
$771,835
|
Robertson, John
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIABC010030
|
$806,557
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
BKV and JCV vaccine development
|
ZIABC011460
|
$279,821
|
Buck, Christopher
|
CCR (NCI)
|
|
Botulinum Toxin for Painful Cutaneous Leiomyomas
|
ZIABC011177
|
$41,656
|
Kong, Heidi
|
CCR (NCI)
|
|
Building on the success of the adoptive immunotherapy of cancer
|
ZIABC010763
|
$1,096,861
|
Restifo, Nicholas
|
CCR (NCI)
|
|
Cadherin-regulated apoptosis and survival signaling in epithelial cells
|
5R01CA142647-02
|
$361,050
|
HANSEN, STEEN
|
CHILDREN'S HOSPITAL BOSTON
|
|
CALGB Member Site: University of California - San Francisco
|
3U10CA138561-03S1
|
$106,497
|
Ryan, Charles
|
UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
|
|
CANCER AND INFLAMMATION GENETICS
|
ZIABC011300
|
$619,559
|
Dean, Michael
|
CCR (NCI)
|
|
Cancer and Leukemia Group B
|
3U10CA031946-31S1
|
$114,228
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B
|
5U10CA031946-31
|
$7,759,618
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B
|
5U10CA032291-31
|
$495,751
|
Burstein, Harold
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer and Leukemia Group B
|
5U10CA047577-25
|
$99,190
|
CRAWFORD, JEFFREY
|
DUKE UNIVERSITY
|
|
Cancer and Leukemia Group B
|
3U10CA077597-14S1
|
$77,984
|
Liu, Minetta
|
GEORGETOWN UNIVERSITY
|
|
Cancer and Leukemia Group B
|
5U10CA077651-15
|
$212,393
|
Hudis, Clifford
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Cancer and Leukemia Group B
|
5U10CA041287-27
|
$258,606
|
KINDLER, HEDY
|
UNIVERSITY OF CHICAGO
|
|
Cancer and Leukemia Group B
|
5U10CA047559-22
|
$134,116
|
SHEA, THOMAS
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer and Leukemia Group B - Leukemia Correlative Sciences
|
5U10CA101140-10
|
$806,740
|
MARCUCCI, GUIDO
|
OHIO STATE UNIVERSITY
|
|
Cancer and Leukemia Group B - The Ohio State University
|
5U10CA077658-15
|
$487,632
|
BLOOMFIELD, CLARA
|
OHIO STATE UNIVERSITY
|
|
Cancer and Leukemia Group B CCOP Research Base
|
3U10CA037447-27S1
|
$405,901
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B CCOP Research Base
|
5U10CA037447-28
|
$2,286,202
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B Statistical Center
|
5U10CA033601-34
|
$4,701,770
|
SARGENT, DANIEL
|
MAYO CLINIC
|
|
Cancer and Leukemia Group B: RPCI/SUNYAB
|
5U10CA059518-20
|
$191,331
|
LEVINE, ELLIS
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Cancer cell adaptation to metabolic stress
|
5P01CA104838-09
|
$1,187,477
|
Simon, Marie
|
UNIVERSITY OF PENNSYLVANIA
|
|
Cancer Center Core Support Grant
|
3P30CA016086-36S1
|
$76,572
|
EARP, HENRY
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Core Support Grant
|
5P30CA016086-36
|
$7,071,992
|
EARP, HENRY
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Support (Core) Grant
|
3P30CA016672-37S1
|
$107,460
|
DEPINHO, RONALD
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Cancer Center Support (Core) Grant
|
3P30CA016672-37S2
|
$74,930
|
DEPINHO, RONALD
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Cancer Center Support (Core) Grant
|
5P30CA016672-37
|
$9,988,336
|
DEPINHO, RONALD
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Cancer Center Support Grant
|
2P30CA006516-47
|
$11,164,583
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA006516-47S1
|
$56,572
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA006516-47S2
|
$75,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA006516-47S3
|
$50,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA008748-47S1
|
$75,000
|
THOMPSON, CRAIG
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Cancer Center Support Grant
|
3P30CA008748-47S2
|
$49,732
|
THOMPSON, CRAIG
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|